News Conference News ESC 2024 Trial Challenges Continuation of Oral Anticoagulants During TAVI Todd Neale August 31, 2024
News Conference News ESC 2019 Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints Todd Neale September 11, 2019
News Conference News ESC 2019 Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5 Shelley Wood September 01, 2019
News Conference News ESC 2016 Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC Todd Neale August 28, 2016
Presentation ESC 2016 ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications Presenter: Gilles Montalescot August 28, 2016
News Conference News ESC 2015 Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients L.A. McKeown September 01, 2015
Presentation ESC 2015 Aldosterone Lethal Effects Blockade in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-Up Presenter: Gilles Montalescot August 30, 2015
News Conference News ESC 2015 ALBATROSS: Aldersterone Blockade Fails to Improve Outcomes in Acute MI Caitlin E. Cox August 30, 2015
News Conference News ESC 2014 Another Strike Against Thrombectomy in 1-Year TASTE Results Todd Neale September 02, 2014
News Conference News ESC 2014 ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration Yael L. Maxwell September 01, 2014
News Conference News ESC 2013 ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS Yael L. Maxwell September 01, 2013